Avatrombopag and Impurities
Ref: 4Z-A-315038
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315027
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315045
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315012
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315046
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 4Z-A-315008
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Avatrombopag maleate
CAS:677007-74-8
Avatrombopag (AKR-501/E5501) is an oral TPO receptor agonist for thrombocytopenia treatment, approved in 2018.
Formula:
C33H38Cl2N6O7S2
Color and Shape:
Liquid
Molecular weight:
765.72
Ref: TM-T68888
25mg | 1,418.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,331.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024